NCT01764841 Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) Status COMPLETED Phase PHASE3
NCT01688180 The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis Status UNKNOWN Phase N/A
NCT01684683 The Effect of Theophylline in the Treatment of Bronchiectasis Status COMPLETED Phase PHASE4
NCT01677403 A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis Status UNKNOWN Phase PHASE4
NCT01615484 Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability Status COMPLETED Phase NA
NCT01463371 Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis Status COMPLETED Phase NA
NCT01410422 Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis Status UNKNOWN Phase N/A
NCT01354912 The Incidence of Nontuberculous Mycobacterial Pulmonary Infection in Bilateral Bronchiectasis and Bronchiolitis Status UNKNOWN Phase N/A
NCT01314716 Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE3
NCT01313624 Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE3
NCT01300403 Physiological Effects of Expiration With the Glottis Open in Lateral Posture (ELTGOL) and Flutter Valve in Patients With Bronchiectasis Status COMPLETED Phase NA
NCT01299194 Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa Status COMPLETED Phase PHASE4
NCT01299181 A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE4
NCT01270074 Prevention of Bronchiectasis in Infants With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT01255592 Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis Status COMPLETED Phase PHASE2